Pharmaceutical Technology42m
Health Canada approves GSK’s Ojjaara for myelofibrosis in anaemia patients
Health Canada has granted approval for GlaxoSmithKline’s ( GSK) Ojjaara (momelotinib) for treating myelofibrosis (MF) in ...
Future Market Insights38m
Global Small Molecule API Market Set to Reach USD 186,941.2 Million by 2034, Growing at a CAGR of 4.5%
Y-o-Y Growth and Strong Performance in 2024 The Small Molecule API market is anticipated to exhibit a Y-o-Y growth of 4.6% in ...